Role of macrophages in peritoneal dialysis-associated peritoneal fibrosis
Peritoneal dialysis (PD) can be used as renal replacement therapy when chronic kidney disease (CKD) progresses to end-stage renal disease. However, peritoneal fibrosis (PF) is a major cause of PD failure. Studies have demonstrated that PD fluid contains a significantly larger numbers of macrophages...
Saved in:
| Main Authors: | Chenling Chu, Ying Huang, Luxi Cao, Shuiyu Ji, Bin Zhu, Quanquan Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2474203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research advances of endothelial-mesenchymal transition during peritoneal dialysis-related peritoneal fibrosis
by: Liao Meng, et al.
Published: (2021-01-01) -
Inhibitory effect of melatonin on peritoneal fibrosis in rats and its mechanism
by: ZHAO Hua, et al.
Published: (2017-01-01) -
Research advances of interleukin-6 in peritoneal dialysis-related complications
by: Yang Fan, et al.
Published: (2021-01-01) -
Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01) -
Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities
by: Narayan Prasad, et al.
Published: (2025-08-01)